Forgot your password?

Forgot your username?

database > company
HeartForce Medical
1818 CORNWALL AVE
Vancouver, British Columbia V6J 1C7 Canada
phone:
fax:
Symbol private
Founded 0
Employees
Research Sector
Summary Description
Digital Ballistocardiograph measures mechanical heart function in all phases
Management
Dr. Geoff Houlton, President, CEO, & Chief Medical Officer; Issa Nakhleh, Chief Financial Officer; Heidi Eaves, Senior Manager, Development and Human Resources; Gonzalo Portacio, Manager, Clinical Development; Dr. Melonie Burrows, Manager, Research Initiatives
Keywords
cardiac cycle, heart muscle contractions, seismic signal, ballistocardiograph, sensor

Comment | Printable Version | Modify profile |
Updated: Jan. 02, 2012

Description
Heart Force Medical Inc. (HFM) has developed a non-invasive, standalone, portable device with which physicians can quickly measure the mechanical function of the heart in both the systolic and diastolic phases. The Digital Ballistocardiograph (dBG300®) captures forces generated as a result of heart muscle contractions with an accelerometer enclosed in a sensor placed on the chest at the lower end of the sternum, thereby enabling precise measurement of all events in the cardiac cycle and displaying the relative changes in the forces generated as the atria and the ventricles contract. A PC displays the dBG300®, a digitized seismic signal, and an electrocardiograph (ECG) signal as a set of waveforms. The dBG300® provides immediate data regarding the timing of cardiac events immediately during the patient’s visit, without the need for an echocardiogram. The device is intended to be used as part of a physician’s overall assessment of a patient either in a busy office or hospital setting, and complements the range of relatively simple instruments that physicians already employ. This later-stage medical device company has received USFDA Clearance and approval from Health Canada for the dBG300®, with intellectual property and patents underway.